Status:

COMPLETED

Naltrexone in the Treatment of Trichotillomania

Lead Sponsor:

University of Chicago

Conditions:

Trichotillomania

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

This is an 8-week, double-blind study of Natrexone in the treatment of trichotillomania

Detailed Description

The goal of the proposed study is to evaluate the efficacy of Naltrexone in trichotillomania. Forty subjects with DSM-IV trichotillomania will receive 8 weeks of double-blind Naltrexone or placebo. Th...

Eligibility Criteria

Inclusion

  • men and women age 18-75;
  • current DSM-IV trichotillomania;
  • hair-pulling primarily due to urges/cravings; and 4) pulling is reported as pleasurable the majority of time.

Exclusion

  • unstable medical illness or clinically significant abnormalities on pre-study laboratory tests or physical examination;
  • history of seizures;
  • myocardial infarction within 6 months;
  • current pregnancy or lactation, or inadequate contraception in women of childbearing potential;
  • clinically significant suicidality;
  • current or recent (past 3 months) DSM-IV substance abuse or dependence;
  • illegal substance within 2 weeks of study initiation;
  • initiation of psychotherapy or behavior therapy from a mental health professional for the treatment of trichotillomania within 3 months prior to study baseline;
  • initiation of a psychotropic medication within 2 months prior to study inclusion;
  • previous treatment with naltrexone; and
  • treatment with investigational medication or depot neuroleptics within 3 months, with fluoxetine within 6 weeks, or with other psychotropics within 2 weeks prior to study baseline;
  • lifetime history of DSM-IV bipolar disorder type I, dementia, or schizophrenia or any other DSM-IV psychotic disorder;
  • current use of opiates.

Key Trial Info

Start Date :

August 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2012

Estimated Enrollment :

51 Patients enrolled

Trial Details

Trial ID

NCT00775229

Start Date

August 1 2008

End Date

December 1 2012

Last Update

February 23 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Chicago

Chicago, Illinois, United States, 60615